All Relations between Schizophrenia and Risperidone

Publication Sentence Publish Date Extraction Date Species
Edoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, Maria Rosaria Muscatello, Umberto Micò, Giuseppina D'Amico, Emilio Perucc. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. Therapeutic drug monitoring. vol 28. issue 5. 2007-01-09. PMID:17038872. the effect of lamotrigine on the steady-state plasma concentrations of the atypical antipsychotics clozapine, olanzapine, and risperidone was investigated in patients with schizophrenia or bipolar disorder stabilized on chronic treatment with clozapine (200-500 mg/day; n = 11), risperidone (3-6 mg/day; n = 10) or olanzapine (10-20 mg/day; n = 14)). 2007-01-09 2023-08-12 Not clear
Berna Binnur Kivircik Akdede, A Elif Anil Yağcioğlu, Köksal Alptekin, Tolga I Turgut, Mevhibe Tümüklü, M Kâzim Yazici, Karu Jayathilake, Zeliha Tunca, Ahmet Göğüş, Herbert Y Meltze. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. The Journal of clinical psychiatry. vol 67. issue 12. 2007-01-09. PMID:17194269. a double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. 2007-01-09 2023-08-12 Not clear
Berna Binnur Kivircik Akdede, A Elif Anil Yağcioğlu, Köksal Alptekin, Tolga I Turgut, Mevhibe Tümüklü, M Kâzim Yazici, Karu Jayathilake, Zeliha Tunca, Ahmet Göğüş, Herbert Y Meltze. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. The Journal of clinical psychiatry. vol 67. issue 12. 2007-01-09. PMID:17194269. the aim of this study was to compare the effect of risperidone or placebo on cognitive function in patients with schizophrenia who were previously treated with clozapine monotherapy. 2007-01-09 2023-08-12 Not clear
Steven G Potkin, Georges M Gharabawi, Andrew J Greenspan, Ramy Mahmoud, Colette Kosik-Gonzalez, Marcia F T Rupnow, Cynthia A Bossie, Michael Davidson, Victoria Burtea, Young Zhu, Jintendra K Trived. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophrenia research. vol 85. issue 1-3. 2006-12-28. PMID:16797162. a double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. 2006-12-28 2023-08-12 Not clear
Steven G Potkin, Georges M Gharabawi, Andrew J Greenspan, Ramy Mahmoud, Colette Kosik-Gonzalez, Marcia F T Rupnow, Cynthia A Bossie, Michael Davidson, Victoria Burtea, Young Zhu, Jintendra K Trived. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophrenia research. vol 85. issue 1-3. 2006-12-28. PMID:16797162. this study compared the effects of atypical antipsychotics (risperidone or quetiapine) with placebo and with each other in recently exacerbated patients with schizophrenia requiring hospitalization. 2006-12-28 2023-08-12 Not clear
Moon-Soo Lee, Young-Hoon Ko, Sang-Hoon Lee, Yong-Jin Seo, Seung-Hyun Kim, Sook-Haeng Joe, Chang-Su Han, Jung-Ho Lee, In-Kwa Jun. Long-term treatment with long-acting risperidone in Korean patients with schizophrenia. Human psychopharmacology. vol 21. issue 6. 2006-12-22. PMID:16915580. long-term treatment with long-acting risperidone in korean patients with schizophrenia. 2006-12-22 2023-08-12 Not clear
Matthew J Byerly, Paul A Nakonezny, Brianne Magouirk Bettcher, Thomas Carmody, Robert Fisher, A John Rus. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16730951. sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. 2006-12-20 2023-08-12 Not clear
T J Raedler, A Schreiner, D Naber, K Wiedeman. Gender-specific effects in the treatment of acute schizophrenia with risperidone. Pharmacopsychiatry. vol 39. issue 5. 2006-12-15. PMID:16944407. gender-specific effects in the treatment of acute schizophrenia with risperidone. 2006-12-15 2023-08-12 Not clear
James L Reilly, Margret S H Harris, Matcheri S Keshavan, John A Sweene. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Archives of general psychiatry. vol 63. issue 11. 2006-12-12. PMID:17088499. adverse effects of risperidone on spatial working memory in first-episode schizophrenia. 2006-12-12 2023-08-12 Not clear
Qinghe Xing, Rui Gao, Huafang Li, Guoyin Feng, Mingqing Xu, Shiwei Duan, Junwei Meng, Aiping Zhang, Shengying Qin, Lin H. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics. vol 7. issue 7. 2006-12-01. PMID:17054409. polymorphisms of the abcb1 gene are associated with the therapeutic response to risperidone in chinese schizophrenia patients. 2006-12-01 2023-08-12 Not clear
Qinghe Xing, Rui Gao, Huafang Li, Guoyin Feng, Mingqing Xu, Shiwei Duan, Junwei Meng, Aiping Zhang, Shengying Qin, Lin H. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics. vol 7. issue 7. 2006-12-01. PMID:17054409. for this purpose, 130 chinese schizophrenia patients undergoing risperidone treatment were recruited. 2006-12-01 2023-08-12 Not clear
William T Carpente. Schizophrenia: risperidone and olanzapine increase time to discontinuation compared with quetiapine and ziprasidone. Evidence-based mental health. vol 9. issue 4. 2006-11-21. PMID:17065303. schizophrenia: risperidone and olanzapine increase time to discontinuation compared with quetiapine and ziprasidone. 2006-11-21 2023-08-12 Not clear
Bruce L Lambert, Francesca E Cunningham, Donald R Miller, Gregory W Dalack, Kwan Hu. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. American journal of epidemiology. vol 164. issue 7. 2006-10-27. PMID:16943266. diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. 2006-10-27 2023-08-12 Not clear
Chul Lee, Kuang-Hsien Wu, Hussain Habil, Yulia Dyachkova, Phil Le. Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia. The Australian and New Zealand journal of psychiatry. vol 40. issue 5. 2006-10-26. PMID:16683970. treatment with olanzapine, risperidone or typical antipsychotic drugs in asian patients with schizophrenia. 2006-10-26 2023-08-12 Not clear
Chul Lee, Kuang-Hsien Wu, Hussain Habil, Yulia Dyachkova, Phil Le. Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia. The Australian and New Zealand journal of psychiatry. vol 40. issue 5. 2006-10-26. PMID:16683970. to examine clinical outcomes in asian patients with schizophrenia receiving monotherapy with olanzapine, risperidone or typical antipsychotics in naturalistic settings. 2006-10-26 2023-08-12 Not clear
George M Simpson, Ramy A Mahmoud, Robert A Lasser, Mary Kujawa, Cynthia A Bossie, Ibrahim Turkoz, Steven Rodriguez, Georges M Gharabaw. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry. vol 67. issue 8. 2006-10-11. PMID:16965196. a 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. 2006-10-11 2023-08-12 Not clear
George M Simpson, Ramy A Mahmoud, Robert A Lasser, Mary Kujawa, Cynthia A Bossie, Ibrahim Turkoz, Steven Rodriguez, Georges M Gharabaw. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry. vol 67. issue 8. 2006-10-11. PMID:16965196. this study examined the effects of 2 doses of long-acting risperidone injection in patients with schizophrenia or schizoaffective disorder. 2006-10-11 2023-08-12 Not clear
Zhi-ling Zhou, Xin Li, Huai-yan Peng, Xi-yong Yu, Ming Yang, Feng-li Su, Feng Wang, Rong-hua Zhu, Chun-yu Deng, Qiu-xiong Lin, Chuan-yue Wang, Wen-biao Li, Shu-guang Lin, Huan-de L. Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia. Acta pharmacologica Sinica. vol 27. issue 3. 2006-10-02. PMID:16490177. multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in chinese female patients with schizophrenia. 2006-10-02 2023-08-12 Not clear
Zhi-ling Zhou, Xin Li, Huai-yan Peng, Xi-yong Yu, Ming Yang, Feng-li Su, Feng Wang, Rong-hua Zhu, Chun-yu Deng, Qiu-xiong Lin, Chuan-yue Wang, Wen-biao Li, Shu-guang Lin, Huan-de L. Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia. Acta pharmacologica Sinica. vol 27. issue 3. 2006-10-02. PMID:16490177. to study the multiple dose clinical pharmacokinetics of risperidone and its main active metabolite, 9-hydroxyrisperidone, in chinese female patients with schizophrenia. 2006-10-02 2023-08-12 Not clear
Hans-Jürgen Mölle. Long-acting risperidone: focus on safety. Clinical therapeutics. vol 28. issue 5. 2006-09-29. PMID:16861087. long-acting risperidone (lar), the first long-acting injectable atypical anti-psychotic, has been found to be effective in the treatment of schizophrenia and schizoaffective disorder. 2006-09-29 2023-08-12 Not clear